Improve Healthcare

Democratizing Diagnostic Testing for Preventable Diseases w/MainzBiomed CEO Guido Baechler

September 19, 2022 Guido Baechler Season 8 Episode 4
Improve Healthcare
Democratizing Diagnostic Testing for Preventable Diseases w/MainzBiomed CEO Guido Baechler
Show Notes

Guido Baechler is CEO and Director at Mainz Biomed (NASDAQ: MYNZ) a leading developer of market-ready molecular genetic diagnostic solutions for life-threatening conditions. The Company's flagship product is ColoAlert, an accurate, non-invasive, and easy-to-use early detection  test for colorectal cancer.

Guido has 30 years of global experience leading public & private life sciences companies having held senior executive roles at Singulex and SummerBio, and at Roche, where he led Roche Molecular’s global program management. 


Learn more @MainzBiomed